[Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432].
D000818:Animals; D001688:Biological Products / Q000627:therapeutic use*; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000378:metabolism; D007167:Immunotherapy; D007376:Interleukin-2 / Q000276:immunology; D008114:Liver Neoplasms, Experimental / Q000628:therapy; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000628:therapy*; D010844:Picibanil / Q000627:therapeutic use*; D010954:Plasmacytoma / Q000628:therapy; D013154:Spleen / Q000166:cytology
D001688:Biological Products; D004273:DNA, Neoplasm; D007376:Interleukin-2; D010844:Picibanil